IOL Chemicals & Pharmaceuticals Share Price | IOL Chemicals & Pharmaceuticals Stock Screener
IOLCP
Pharmaceuticals
Share Price NSE
₹128.98
▼
-2.42 (-1.84%)
Share Price BSE
₹128.69
▼
-2.65 (-2.02%)
As of May 29, 2026, the IOL Chemicals & Pharmaceuticals share price (NSE: IOLCP) is ₹128.98 on NSE and ₹128.69 on BSE, down 1.84% from the previous close, with shares trading between ₹128.02 and ₹132.92, and a 52-week range of ₹68.21–₹136.06.
Check IOLCP 52-week performance for the annual price range and momentum.
Use the IOL Chemicals & Pharmaceuticals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
IOL Chemicals & Pharmaceuticals Market Cap
₹3,485.05 Cr.
IOLCP P/E Ratio (TTM)
25.85
IOL Chemicals & Pharmaceuticals P/B Ratio
1.98
EPS (TTM)
₹4.69
Dividend Yield
0.82%
Debt to Equity
0.05
IOLCP 52 Week High
₹136.06
IOL Chemicals & Pharmaceuticals 52 Week Low
₹68.21
Operating Margin
15.00%
Profit Margin
8.53%
IOLCP Revenue (TTM)
₹621.00
EBITDA
₹94.00
Net Income
₹53.00
Total Assets
₹2,587.00
Total Equity
₹1,799.00
IOL Chemicals & Pharmaceuticals Share Price Chart
Screen IOL Chemicals & Pharmaceuticals share price with an interactive chart. Analyse IOLCP price trends and volatility across different timeframes.
IOL Chemicals & Pharmaceuticals Company Profile - Fundamental Screener
Screen IOL Chemicals & Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for IOLCP shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE485C01029
IOL Chemicals & Pharmaceuticals Balance Sheet Screener
Screen IOLCP balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 2,587 | 2,382 | 2,244 | 2,022 | 1,962 |
| Current Assets | 1,228 | 1,151 | 1,120 | 920 | 1,081 |
| Fixed Assets | 1,277 | 1,171 | 933 | 752 | 561 |
| Liabilities | |||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 98 | 85 | 73 | 58 | 57 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 1,799 | 1,688 | 1,612 | 1,508 | 1,392 |
| Share Capital | 59 | 59 | 59 | 59 | 59 |
| Reserves & Surplus | 1,740 | 1,629 | 1,553 | 1,449 | 1,334 |
IOL Chemicals & Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen IOL Chemicals & Pharmaceuticals income statement and profit fundamentals.
Analyze IOLCP quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for IOL Chemicals & Pharmaceuticals share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 621 | 532 | 559 | 574 | 586 | 511 | 510 | 532 | 527 | 596 | 570 | 552 | 529 | 579 | 570 |
| Expenses | 527 | 465 | 490 | 511 | 534 | 454 | 451 | 484 | 476 | 492 | 491 | 481 | 476 | 527 | 509 |
| EBITDA | 94 | 67 | 70 | 64 | 51 | 57 | 59 | 48 | 51 | 104 | 80 | 71 | 53 | 52 | 61 |
| Operating Profit % | 15.00% | 12.00% | 11.00% | 10.00% | 8.00% | 10.00% | 10.00% | 8.00% | 9.00% | 16.00% | 13.00% | 12.00% | 9.00% | 8.00% | 10.00% |
| Depreciation | 20 | 19 | 20 | 20 | 20 | 16 | 17 | 18 | 19 | 12 | 14 | 16 | 16 | 11 | 11 |
| Interest | 3 | 4 | 4 | 4 | 4 | 3 | 2 | 4 | 5 | 5 | 4 | 4 | 4 | 2 | 3 |
| Profit Before Tax | 71 | 45 | 46 | 41 | 28 | 37 | 40 | 26 | 28 | 87 | 61 | 51 | 32 | 39 | 47 |
| Tax | 18 | 13 | 12 | 11 | 7 | 10 | 10 | 7 | 7 | 22 | 15 | 13 | 9 | 9 | 12 |
| Net Profit | 53 | 31 | 34 | 30 | 21 | 28 | 30 | 19 | 21 | 65 | 46 | 38 | 23 | 30 | 35 |
| EPS | 1.81 | 1.07 | 1.16 | 1.02 | 0.70 | 4.71 | 5.11 | 3.26 | 3.50 | 11.03 | 7.81 | 6.45 | 3.93 | 5.07 | 5.91 |
IOL Chemicals & Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen IOLCP cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | 179 | 290 | 122 | 93 |
| Investing Activities | -154 | -191 | -120 | -121 |
| Financing Activities | 46 | -93 | -4 | -2 |
| Net Cash Flow | 71 | 6 | -2 | -29 |
IOL Chemicals & Pharmaceuticals Shareholding Pattern Screener
See IOL Chemicals & Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings.
Check IOL Chemicals & Pharmaceuticals promoter holding and ownership changes for IOLCP on TickJournal.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 57.48% | 52.62% | 52.62% | 52.62% | 52.62% | 52.62% | 48.19% | 48.19% |
| FII Holding | 1.72% | 2.08% | 2.25% | 2.59% | 1.47% | 1.49% | 1.63% | 1.39% |
| DII Holding | 0.02% | 0.03% | 0.04% | 0.02% | 0.07% | 0.08% | 0.08% | 0.10% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 31.03% | 30.51% | 29.97% | 30.22% | 31.43% | 31.23% | 31.31% | 31.48% |
| Other Holding | 9.74% | 14.76% | 15.12% | 14.54% | 14.40% | 14.58% | 18.79% | 18.84% |
| Shareholder Count | 131,550 | 133,531 | 136,129 | 125,040 | 130,002 | 126,701 | 125,979 | 128,689 |
IOL Chemicals & Pharmaceuticals Share Dividend Screener - Share Yield Analysis
Check IOL Chemicals & Pharmaceuticals dividend history with payout and yield data.
View IOL Chemicals & Pharmaceuticals dividend details including ex-dates and amounts for IOLCP stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.80 | 1.10% |
| 2024-March | ₹5.00 | 8.18% |
| 2023-March | ₹4.00 | 5.53% |
| 2022-March | ₹4.00 | 7.07% |
| 2021-March | ₹6.00 | 8.48% |
| 2020-March | ₹3.00 | 2.72% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
IOL Chemicals & Pharmaceuticals Stock Index Membership
See which indices include IOL Chemicals & Pharmaceuticals stock.
Check IOLCP index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
IOL Chemicals & Pharmaceuticals Market Events Screener - Corporate Actions
Get IOL Chemicals & Pharmaceuticals corporate actions including splits, bonuses, and buybacks.
Check IOL Chemicals & Pharmaceuticals stock events that may affect IOLCP share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 7.73% | ||
| Dividend | ₹ 2.00 /share | -22.67% | ||
| 2026-05-20 | 2026-05-20 | Quarterly Result Announcement | NA | 4.26% |
| 2026-02-17 | 2026-02-17 | Dividend | ₹ 1.00 /share | -7.50% |
| 2026-02-11 | 2026-02-11 | Quarterly Result Announcement | NA | 12.36% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | -5.32% |
| 2025-08-22 | 2025-08-22 | Annual General Meeting | NA | 27.43% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | 0.92% |
| 2025-05-16 | 2025-05-16 | Quarterly Result Announcement | NA | 18.62% |
| 2025-03-11 | 2024-12-27 | Split | 2:10 | 0.00% |
| 2025-02-18 | 2025-02-18 | Dividend | ₹ 4.00 /share | -7.33% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | 1.31% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -6.34% |
| 2024-08-23 | 2024-08-23 | Annual General Meeting | NA | 24.87% |
| 2024-02-16 | 2024-02-16 | Dividend | ₹ 5.00 /share | -6.06% |
IOL Chemicals & Pharmaceuticals Competitors Screener - Peer Comparison
Screen IOLCP competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 442,581 | 41.43 | 54,729 | 9.71% | 10,980 | 54.75 |
| Divis Laboratories | 182,828 | 73.47 | 9,712 | 18.67% | 2,191 | 66.48 |
| Torrent Pharmaceuticals | 151,833 | 66.60 | 11,539 | 6.99% | 1,911 | 61.90 |
| Cipla | 113,025 | 29.32 | 27,712 | -2.46% | 3,783 | 61.92 |
| Dr Reddys Laboratories | 109,105 | 26.47 | 33,593 | -0.44% | 3,998 | 52.61 |
| Zydus Life Science | 104,543 | 20.35 | 26,720 | 13.65% | 5,242 | 69.40 |
| Lupin | 104,288 | 19.51 | 27,488 | 19.98% | 5,345 | 47.33 |
| Mankind Pharma | 102,351 | 53.58 | 14,278 | 12.03% | 1,750 | 62.34 |
| Aurobindo Pharma | 85,000 | 25.77 | 32,346 | 9.43% | 3,484 | 52.91 |
| Laurus Labs | 72,530 | 81.91 | 6,813 | 21.03% | 884 | 77.10 |
IOL Chemicals & Pharmaceuticals Company Announcements - News Screener
Screen IOLCP latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-28 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-05-28 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-27 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-27 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-26 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-26 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-26 | Comments Of Board Of Directors | - |
| 2026-05-26 | Fixed 39Th Annual General Meeting Of The Company And Book Closure Of Register Of Members | - |
| 2026-05-26 | Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Audited Financial Results For The Quarter And Year Ended 31St March 2026 | - |
| 2026-05-26 | Outcome Of The Board Meeting And Submission Of Audited Financial Results For The Quarter And Year Ended 31St March 2026 | - |
| 2026-05-24 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-13 | Board Meeting Intimation for Notice Of The Board Meeting | - |
| 2026-05-09 | Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-04-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-04-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-04-09 | Disclosure Under Regulation 30 - Participation In Saksham Niveshak Campaign | - |
| 2026-04-04 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-04-01 | Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-03-26 | Closure of Trading Window | - |
| 2026-03-20 | Disclosure Under SEBI (Prohibition Of Insider Trading Regulation) 2015 | - |